000 | 04933nam a22004815i 4500 | ||
---|---|---|---|
999 |
_c200456925 _d75137 |
||
003 | DE-He213 | ||
005 | 20231109085732.0 | ||
007 | cr nn 008mamaa | ||
008 | 221224s2022 sz | s |||| 0|eng d | ||
020 | _a9783031154782 | ||
024 | 7 |
_a10.1007/978-3-031-15478-2 _2doi |
|
040 |
_aTR-AnTOB _beng _cTR-AnTOB _erda |
||
060 | 0 | 0 | _aWC 506.5 |
072 | 7 |
_aMJD _2bicssc |
|
072 | 7 |
_aMED010000 _2bisacsh |
|
072 | 7 |
_aMJD _2thema |
|
096 | _aWC506.5EBK | ||
245 | 1 | 0 |
_aCardiovascular Complications of COVID-19 _h[electronic resource] : _bAcute and Long-Term Impacts / _cedited by Maciej Banach. |
250 | _a1st ed. 2022. | ||
264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Humana, _c2022. |
|
300 | _a1 online resource | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aContemporary Cardiology, _x2196-8977 |
|
505 | 0 | _aPart I: Introduction -- Biology of SARS-CoV-2 coronavirus; origin, structure, and variants -- Epidemiology of COVID-19 -- Clinical symptoms and course of COVID-19 -- Risk factors of developing COVID-19 and its severe course -- Prognosis in COVID-19 patients - statistics, risk factors -- Part II: Cardiovascular Implications of the Acute Phase of COVID-19 -- Myocardial injury in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) -- Acute coronary syndrome – destabilization of atherosclerotic plaque in COVID-19 (epidemiology, influence on prognosis, pathogen-esis and treatment) -- Acute Vascular Injury in COVID-19 -- Heart failure and acute circulatory failure in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) -- Cardiomyopathy in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) -- Arrhythmias in COVID-19 -- Thromboembolic events in COVID-19 -- Stroke in COVID-19 -- Pulmonary embolism after COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) -- Interaction of anti-COVID-19 drugs with cardiovascular therapy -- Part III: Influence of the Treatment of Cardiovascular Diseases on the Course of COVID-19 -- Beyond the vaccines-Bioactive lipids in COVID-19 -- Statins and COVID-19 (mechanism of action, effect on prognosis) -- Covid-19 And Antihypertensive Treatment -- Colchicine in COVID-19 (mechanism of action, effect on prognosis) -- Antiplatelet drugs in COVID-19: mechanism of action and effect on prognosis -- Antidiabetic drugs in COVID-19 -- Part IV: Cardiovascular Complications of Long-COVID-19 -- Long COVID-19 - Definition, Epidemiology, and Clinical Implications -- Cardiovascular complications of long COVID-19 - prevalence, diagnosis and risk factors -- Cardiovascular complications of Long-COVID – management -- Part V The impact of COVID-19 pandemic on the e-services and digital tools development in medicine -- The impact of the COVID-19 pandemic on e-services and digital tools development in medicine. | |
520 | _aThis book is the first comprehensive approach on COVID-19 cardiac complications, both during the acute phase as well as in the long-COVID period. It provides an up-to-date and highly illustrated summary of the biology of SARS-CoV-2, the course of COVID-19, risk factors that worsen the disease in COVID-19 patients, clinical features of COVID-19 patients, COVID-19 cardiological complications, treatment, and prevention methods, and long-term cardiological aspects of COVID-19. Chapters provide the reader with a contemporary perspective on the emerging links between COVID-19 and cardiovascular disease. In addition, this volume discusses the clinical implications and therapeutic goals in patients with COVID-19 and cardiac complications, as well as possible therapeutic options. It also offers clear recommendations on how to manage (both non- and pharmacologically) to avoid the increased number of COVID-19 related deaths due to CVD and its risk factors. Cardiovascular Complications of COVID-19 will be the primary resource for physicians, residents, fellows, and nursed and medical students in the fields of cardiology and COVID-19/infectious diseases as well as healthcare providers that initiate preventive activities and dedicated programs. | ||
650 | 0 | _aCardiology. | |
650 | 1 | 4 | _aCardiology. |
653 | 0 | _aCOVID-19 -- complications | |
653 | 0 | _aCardiovascular Diseases -- etiology | |
700 | 1 |
_aBanach, Maciej. _eeditor. _0(orcid)0000-0001-6690-6874 _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
830 | 0 |
_aContemporary Cardiology, _x2196-8977 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-031-15478-2 _3Springer eBooks _zOnline access link to the resource |
942 |
_2NLM _cEBK |
||
041 | _aeng |